North America Skin Cancer Dermatology Market: Current Analysis and Forecast (2022-2028)
$3999 – $6999
Emphasis on Test Type (Skin Biopsy, Diagnostic Imaging); By Facility Type (Hospital Outpatient Departments, Stand-alone Practices, Multispecialty Clinics); By Age Group (0-19, 20-39, 40-64, 65-84, and 85 and above); and Country
The North America skin cancer dermatology market is expected to grow at a strong CAGR of around 6%. North America skin cancer dermatology market is anticipated to witness a surge in the availability of technologically advanced surgeries or procedures in hospitals and clinics such as dermatoscopy, skin biopsy, diagnostic imaging, and lymph node biopsy. This along with the rapidly growing skin cancer cases across the country is causing an increase in the number of patients and diagnoses. For instance, in July 2020, Genentech, a member of the Roche Group, stated that the U.S. Food and Drug Administration (FDA) sanctioned Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients. Moreover, the most common cause of death caused due to melanoma due to climate change increasing sun exposure. Approx. 7,990 people are expected to die of melanoma as per the American Cancer Society, in 2023. Therefore, the demand for North America skin cancer dermatology is anticipated to grow in the forthcoming years.
Some of the major players operating in the market include Speclipse, Inc.; Agilent Technologies, Inc.; MetaOptima Technology Inc.; FotoFinder Systems, Inc; Canfield Scientific, Inc.; SkinIO, Inc.; Firefly Health, Inc.; DermLite; Eli Lilly and Company; Bristol-Myers Squibb Company Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst test type, skin biopsy segment held a significant market share in 2021”
Based on test type, the North America skin cancer dermatology market is segmented into skin biopsy and diagnostic imaging. The skin biopsy segment held a significant market share in 2021. This is mainly due to the higher adoption of the skin biopsy procedure due to the diagnosis of an extensive range of skin disorders for example basal cell carcinoma, squamous cell carcinoma, melanoma, and dermatitis. For instance, on May 18, 2022, LabCorp introduced the LAG-3 IHC assay, which is a new test for skin cancer treatment. The new assay measures Lymphocyte-activation gene 3 (LAG-3) expression levels by immunohistochemistry (IHC) in tumor tissue.
“Amongst age group, the 40-64 segment is expected to grow with a significant CAGR during the forecast period”
Based on age group, the market is segmented into 0-19, 20-39, 40-64, 65-84, and 85 and above. As per our analysis, the 40-64 segment is expected to grow with a significant CAGR during the forecast period. This is mainly attributed to the prolonged sun exposure with the rising rate of new melanomas of the skin cancer by age group that cause high demand of tanning kit among the population.
North America Skin Cancer Dermatology Market Report Coverage
“Canada is expected to grow”
Canada expected to grow with a significant CAGR during the forecast period owing to the well-established dermatology medical specialty in Canada, with dermatologists playing a crucial role in the diagnosis, treatment, and management of skin diseases, including skin cancer. The Canadian Dermatology Association has played a crucial role in promoting the specialty and supporting the needs of dermatologists and their patients. Additionally, advances in technology and research have led to the development of new and more effective treatments for skin cancer, including immunotherapy and targeted therapy. As per the Canadian Skin Cancer Foundation in 2022, around 80,000 cases of skin cancer are diagnosed in Canada each year, and above 5,000 of these are melanoma, which is the deadliest form of skin cancer. Therefore, the above-mentioned factors fuel the growth of skin cancer dermatology in the country.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The North America skin cancer dermatology market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
|2.1.||Research Process of the North America Skin Cancer Dermatology Market|
|2.2.||Research Methodology of the North America Skin Cancer Dermatology Market|
|5||NORTH AMERICA SKIN CANCER DERMATOLOGY MARKET COVID-19 IMPACT|
|6||NORTH AMERICA SKIN CANCER DERMATOLOGY MARKET REVENUE, 2020-2028F|
|8.1.||Hospital Outpatient Departments|
|9.5.||85 and above|
|10.3.||Rest of North America|
|12||NORTH AMERICA SKIN CANCER DERMATOLOGY MARKET OPPORTUNITIES|
|13||NORTH AMERICA SKIN CANCER DERMATOLOGY MARKET TRENDS|
|14.1.||Demand Side Analysis|
|14.2.||Supply Side Analysis|
|15||VALUE CHAIN ANALYSIS|
|18.1.1.||Porters Fiver Forces Analysis|
|19.2.||Agilent Technologies, Inc.|
|19.3.||MetaOptima Technology Inc.|
|19.4.||FotoFinder Systems, Inc|
|19.5.||Canfield Scientific, Inc.|
|19.7.||Firefly Health, Inc.|
|19.9.||Eli Lilly and Company|
|19.10.||Bristol-Myers Squibb Company|
Research Methodology for the North America Skin Cancer Dermatology Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the North America skin cancer dermatology market were the three major steps undertaken to create and analyze the adoption of North America skin cancer dermatology in major country. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the North America skin cancer dermatology market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the North America skin cancer dermatology market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the North America skin cancer dermatology market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as test type, facility type, and age group. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the North America skin cancer dermatology market. Further, we conducted factor analysis using dependent and independent variables such as test type, facility type, and age group of the North America skin cancer dermatology market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the North America skin cancer dermatology market sector across the country.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the North America skin cancer dermatology market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the North America skin cancer dermatology market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the North America skin cancer dermatology market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the North America skin cancer dermatology market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the test type, facility type, and age group in the North America skin cancer dermatology market.
The main objective of the North America skin cancer dermatology Market Study
The current & future market trends of the North America skin cancer dermatology market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the North America skin cancer dermatology market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the test type, facility type, and age group
- Define and analysis of the regulatory framework for the North America skin cancer dermatology industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the North America skin cancer dermatology market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the North America skin cancer dermatology market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
There are no reviews yet.